secwatch.observer — SEC 8-K summary
======================================

Issuer:     Centessa Pharmaceuticals plc (CNTA)
CIK:        0001847903
Form:       8-K
Filed at:   2022-09-12T23:59:59+00:00
Accession:  0001847903-22-000053
Event type: other_material
Sentiment:  neutral
Materiality: 0.05
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Centessa furnishes corporate presentation; no specific financial or operational updates
--------------------------------------------------------------------------------

- Presentation posted to Investor section of centessa.com as of September 12, 2022.
- No earnings, guidance, pipeline data, or other material disclosures included in the filing.
- Presentation contains standard corporate overview and forward-looking disclaimers only.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1847903/000184790322000053/0001847903-22-000053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1847903/000184790322000053/cnta-20220912.htm
  HTML page:      https://secwatch.observer/filing/0001847903-22-000053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer